Shanghai, China

Hongyang Wang

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2007-2020

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Hongyang Wang

Introduction

Hongyang Wang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of chimeric antigen receptors and monoclonal antibodies. With a total of 4 patents to his name, Wang's work has the potential to impact cancer treatment and immunotherapy.

Latest Patents

Wang's latest patents include groundbreaking inventions such as "Chimeric antigen receptors targeting GPC3 and uses thereof." This patent describes a nucleic acid encoding a chimeric antigen receptor expressed on the surface of T lymphocytes. The chimeric antigen receptor comprises an extracellular binding domain, a transmembrane region, and an intracellular signaling domain. The extracellular binding domain specifically recognizes the C-terminal epitope of GPC3, which is crucial for targeted cancer therapies.

Another notable patent is "P28GANK monoclonal antibody and peptides for preparation thereof and use thereof." This invention provides the sequences of two polypeptides that can be used for the preparation of monoclonal antibodies against human p28. The patent also details the monoclonal antibodies against human p28 and their various applications in medical research.

Career Highlights

Throughout his career, Hongyang Wang has worked with several notable companies, including Carsgen Therapeutics Limited. His work at these organizations has allowed him to advance his research and contribute to innovative solutions in the field of immunotherapy.

Collaborations

Wang has collaborated with esteemed colleagues such as Zonghai Li and Bizhi Shi. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their research.

Conclusion

In summary, Hongyang Wang is a distinguished inventor whose work in biotechnology has led to significant advancements in cancer treatment. His innovative patents and collaborations highlight his commitment to improving healthcare through scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…